Lidocaine HCI Topical Solution Recalled Due to Super Potency
The recalled lot of Lidocaine HCl Topical Solution 4% (40mg/mL) was distributed at the wholesale and retail distribution levels.
Topical Pain Relief
ZTlido Labeling Updated With Clinical Data on Water Exposure
The Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ZTlido® (lidocaine topical system; Scilex Pharmaceuticals) to include additional administration-related data. ZTlido is indicated for the relief of pain associated with postherpetic neuralgia in adults. The product is available as a single-layer, drug-in-adhesive topical delivery system containing 36mg of lidocaine in a…
Evidence Supporting Use of Compounded Topical Pain Creams Limited
“In context of the recent rise in supply and demand of compounded preparations, lack of evidence regarding systemic absorption of ingredients used in compounded topical pain creams gives rise to a substantial public health concern,” the authors concluded.
Perrigo Gets FDA Approval for Over-the-Counter Diclofenac Topical Gel
Perrigo announced that the FDA has approved the abbreviated New Drug Application for its over-the-counter diclofenac sodium topical gel 1% for the temporary relief of arthritis pain in the hand, wrist, elbow, foot, ankle or knee in adults ≥18 years old.
FDA Approves OTC Switch of Diclofenac Gel, Olopatadine Eye Drops
Diclofenac sodium topical gel and olopatadine HCl ophthalmic drops will soon be available over-the-counter (OTC) after the the Food and Drug Administration (FDA) switched the status of these products from prescription to nonprescription.
Compounded Pain Creams Evaluated in Patients With Localized Chronic Pain
To investigate the effectiveness of compounded creams in the treatment of chronic pain conditions, study authors performed a double-blind, randomized, parallel study comparing creams compounded with an active ingredient to placebo creams.
ZTlido Patch for Post-Shingles Pain Launching Soon
The non-aqueous adhesive patch requires 36mg per topical system to achieve the same therapeutic dose as Lidoderm (lidocaine 5%) which contains 700mg per patch.
FDA: Updated Safety Alert Regarding Benzocaine-Associated Methemoglobinemia
The Agency is urging manufacturers to stop marketing OTC oral drug products containing benzocaine for teething to this patient population.
Topical Analgesic Use Improves Pain, Opioid Discontinuation in Study
The analysis evaluated changes in opioid use, other concurrrent medication use, and pain severity and interference in opioid-experienced patients
LETS GEL KIT Available to Prevent Pain When Suturing
The new Convenience Pack includes SuturaGel Methylcellulose Base, which is designed to reduce the amount of medication run-off from the treatment area.
